343 related articles for article (PubMed ID: 27142870)
1. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
Targher G; Marchesini G; Byrne CD
Diabetes Metab; 2016 Jun; 42(3):142-56. PubMed ID: 27142870
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and risk of cardiovascular disease.
Lonardo A; Sookoian S; Pirola CJ; Targher G
Metabolism; 2016 Aug; 65(8):1136-50. PubMed ID: 26477269
[TBL] [Abstract][Full Text] [Related]
3. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
Miele L; Targher G
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
[TBL] [Abstract][Full Text] [Related]
4. NAFLD: a multisystem disease.
Byrne CD; Targher G
J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A
Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease - A multisystem disease?
Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
Mantovani A; Gisondi P; Lonardo A; Targher G
Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Valenti L; Bugianesi E; Pajvani U; Targher G
Liver Int; 2016 Nov; 36(11):1563-1579. PubMed ID: 27276701
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease: Evolving paradigms.
Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
12. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective.
Rhee EJ
Endocrinol Metab (Seoul); 2019 Sep; 34(3):226-233. PubMed ID: 31565874
[TBL] [Abstract][Full Text] [Related]
14. Steatosis and NASH in type 2 diabetes.
Hu M; Phan F; Bourron O; Ferré P; Foufelle F
Biochimie; 2017 Dec; 143():37-41. PubMed ID: 29097281
[TBL] [Abstract][Full Text] [Related]
15. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
Kieć-Wilk B; Klupa T; Dembińska-Kieć A
Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
[TBL] [Abstract][Full Text] [Related]
16. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.
Vanni E; Marengo A; Mezzabotta L; Bugianesi E
Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
[TBL] [Abstract][Full Text] [Related]
19. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
20. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.
Morrison AE; Zaccardi F; Khunti K; Davies MJ
Liver Int; 2019 Mar; 39(3):557-567. PubMed ID: 30358050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
